Clinical needs for transgender men in the gynecologic oncology setting.

[1]  C. Flowers,et al.  Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society , 2020, CA: a cancer journal for clinicians.

[2]  E. New,et al.  Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series. , 2020, The journal of sexual medicine.

[3]  E. Boskey,et al.  Empowering Transmasculine Youth by Enhancing Reproductive Health Counseling in the Primary Care Setting. , 2020, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[4]  Alexandre Buckley de Meritens,et al.  Gynecologic cancer screening in the transgender male population and its current challenges. , 2019, Maturitas.

[5]  A. Puechl,et al.  Care and Cancer Screening of the Transgender Population. , 2019, Journal of women's health.

[6]  M. Adank,et al.  Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands , 2019, BMJ.

[7]  K. Moysich,et al.  Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[8]  V. Gomez-Lobo,et al.  Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series , 2019, American journal of obstetrics and gynecology.

[9]  S. Sutton,et al.  National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Liangzhi Xu,et al.  Association Between Polycystic Ovary Syndrome and Cancer Risk , 2019, JAMA oncology.

[11]  M. Khalifa,et al.  Histologic Features of Hysterectomy Specimens From Female-Male Transgender Individuals , 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[12]  M. Moravek.  Gender-Affirming Hormone Therapy for Transgender Men , 2018, Clinical obstetrics and gynecology.

[13]  A. Scheim,et al.  Experiences of Transgender Men in Accessing Care in Gynecology Clinics [24G] , 2018 .

[14]  S. Reisner,et al.  Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients , 2018, PloS one.

[15]  G. Quinn,et al.  Cancer Screening Considerations and Cancer Screening Uptake for Lesbian, Gay, Bisexual, and Transgender Persons. , 2018, Seminars in oncology nursing.

[16]  Kayla C Gatos.  A Literature Review of Cervical Cancer Screening in Transgender Men. , 2018, Nursing for women's health.

[17]  A. Berchuck,et al.  Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[18]  P. Cohen-Kettenis,et al.  Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline , 2017, The Journal of clinical endocrinology and metabolism.

[19]  PotterJennifer,et al.  Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests , 2017 .

[20]  E. Kobetz,et al.  Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey. , 2017, LGBT health.

[21]  J. Buring,et al.  Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium. , 2017, Cancer research.

[22]  M. H. van den Berg,et al.  Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals , 2017, Human reproduction.

[23]  S. Reisner,et al.  Barriers to Gender Transition-Related Healthcare: Identifying Underserved Transgender Adults in Massachusetts , 2017, Transgender health.

[24]  Shilpen A. Patel,et al.  Cancer care in lesbian, gay, bisexual, transgender and queer populations. , 2017, Future oncology.

[25]  J. Obedin-Maliver,et al.  Gynecologic Care for Transgender Adults , 2017, Current Obstetrics and Gynecology Reports.

[26]  L. Liao,et al.  Epidemiology of vulvar neoplasia in the NIH-AARP Study. , 2017, Gynecologic oncology.

[27]  S. Reisner,et al.  Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests. , 2017, LGBT health.

[28]  H. Harris,et al.  Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review , 2016, Fertility Research and Practice.

[29]  C. Unger.  Hormone therapy for transgender patients , 2016, Translational andrology and urology.

[30]  L. Resta,et al.  Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. , 2016, Taiwanese journal of obstetrics & gynecology.

[31]  D. Ehrmann,et al.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. , 2016, Endocrine reviews.

[32]  Stephen Whittle,et al.  Transgender people: health at the margins of society , 2016, The Lancet.

[33]  E. Coleman,et al.  Barriers to healthcare for transgender individuals , 2016, Current opinion in endocrinology, diabetes, and obesity.

[34]  W. GrimstadFrances,et al.  Assessing Residency Program Approaches to the Transgender Health CREOG Objective. , 2016 .

[35]  C. Satterwhite,et al.  Assessing Residency Program Approaches to the Transgender Health CREOG Objective , 2016, Transgender health.

[36]  G. Hallmans,et al.  Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study , 2016, Hormones and Cancer.

[37]  Evan Taylor,et al.  Cancer's Margins: Trans* and Gender Nonconforming People's Access to Knowledge, Experiences of Cancer Health, and Decision-Making , 2015, LGBT health.

[38]  Susan R Rankin,et al.  The Report of the 2015 U.S. Transgender Survey , 2016 .

[39]  D. Bowen,et al.  Disparities in psychological distress impacting lesbian, gay, bisexual and transgender cancer survivors , 2015, Psycho-oncology.

[40]  Dylan Thomas,et al.  A SIMPLE INTERVENTION RAISED RESIDENT-PHYSICIAN WILLINGNESS TO ASSIST TRANSGENDER PATIENTS SEEKING HORMONE THERAPY. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[41]  C. Unger.  Care of the transgender patient: a survey of gynecologists' current knowledge and practice. , 2015, Journal of women's health.

[42]  I. Gram,et al.  Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition , 2015, International journal of cancer.

[43]  S. Reisner,et al.  Pap test use is lower among female-to-male patients than non-transgender women. , 2014, American journal of preventive medicine.

[44]  M. Rosario,et al.  Mediation by peer violence victimization of sexual orientation disparities in cancer-related tobacco, alcohol, and sexual risk behaviors: pooled youth risk behavior surveys. , 2014, American journal of public health.

[45]  John A. Barry,et al.  Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis , 2014, Human reproduction update.

[46]  P. Hillemanns,et al.  Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. , 2014, The Lancet. Oncology.

[47]  S. Reisner,et al.  Female-to-Male Patients Have High Prevalence of Unsatisfactory Paps Compared to Non-Transgender Females: Implications for Cervical Cancer Screening , 2014, Journal of General Internal Medicine.

[48]  P. V. van Diest,et al.  Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. , 2013, The journal of sexual medicine.

[49]  R. Lobo,et al.  Cancer risk and PCOS , 2013, Steroids.

[50]  R. Banzi,et al.  High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening , 2013, International journal of cancer.

[51]  E. Pearce,et al.  A simple curriculum content change increased medical student comfort with transgender medicine. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[52]  Tsuyoshi Saito,et al.  Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. , 2013, Human reproduction.

[53]  A. Nikolic,et al.  Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy , 2012, World Journal of Surgical Oncology.

[54]  W. J. Meyer,et al.  Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 , 2012 .

[55]  J. Kaufman,et al.  Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy. , 2012, The Journal of clinical endocrinology and metabolism.

[56]  J. Snelgrove,et al.  “Completely out-at-sea” with “two-gender medicine”: A qualitative analysis of physician-side barriers to providing healthcare for transgender patients , 2012, BMC Health Services Research.

[57]  Y. Qiao,et al.  Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method , 2012, Journal of the National Cancer Institute.

[58]  N. Teng,et al.  Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. , 2011, American journal of obstetrics and gynecology.

[59]  L. Gooren.  Clinical practice. Care of transsexual persons. , 2011, The New England journal of medicine.

[60]  Committee Opinion no. 512: health care for transgender individuals. , 2011, Obstetrics and gynecology.

[61]  Stefan Seidl,et al.  Vaginal carcinoma in a female-to-male transsexual. , 2010, The journal of sexual medicine.

[62]  R. Fanchin,et al.  Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. , 2010, Reproductive biomedicine online.

[63]  A. Perrone,et al.  Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. , 2009, The journal of sexual medicine.

[64]  V. Montori,et al.  Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. , 2009, The Journal of clinical endocrinology and metabolism.

[65]  Susan M. Domchek,et al.  Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers , 2009, Journal of the National Cancer Institute.

[66]  B. Andersen,et al.  Psychological and Sexual Aspects of Gynecologic Cancer , 2009 .

[67]  L. Gooren,et al.  Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. , 2008, European journal of endocrinology.

[68]  M. Beckmann,et al.  Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals. , 2008, The Journal of clinical endocrinology and metabolism.

[69]  J. Buring,et al.  Plasma androgen concentrations and risk of incident ovarian cancer. , 2007, American journal of epidemiology.

[70]  L. Sahlin,et al.  Effects of testosterone treatment on endometrial proliferation in postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[71]  J. Chang-Claude,et al.  Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  D. Dizon,et al.  Ovarian Cancer Associated with Testosterone Supplementation in a Female-to-Male Transsexual Patient , 2006, Gynecologic and Obstetric Investigation.

[73]  Samuel Lurie.  Identifying Training Needs of Health-Care Providers Related to Treatment and Care of Transgendered Patients: A Qualitative Needs Assessment Conducted in New England , 2005 .

[74]  D. Driák,et al.  Could a man be affected with carcinoma of cervix?--The first case of cervical carcinoma in trans-sexual person (FtM)--case report. , 2005, Acta medica.

[75]  A. Makris,et al.  Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. , 2003, Breast.

[76]  E. Bloemena,et al.  Ovarian cancer in female-to-male transsexuals: report of two cases. , 2000, Gynecologic oncology.

[77]  P. V. van Kesteren,et al.  The effect of androgen treatment on bone metabolism in female‐to‐male transsexuals , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[78]  I. Ganly,et al.  Breast cancer in a trans‐sexual man receiving hormone replacement therapy , 1995, The British journal of surgery.

[79]  R. Reid,et al.  Polycystic ovaries are a common finding in untreated female to male transsexuals , 1993 .

[80]  W. Futterweit,et al.  Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals , 1986 .